Weapons, drugs, alcohol and cigarettes have been seized by Revenue in multiple search operations across Ireland. Detector ...

A drug used to treat insomnia has protected mice against the buildup of the tau protein found to clump abnormally in ...

Q. We’ve been hearing lately about using ketamine, a thought that scares me to death. Here’s my story: I was on a gurney ...

A. Regular reliance on zolpidem to get to sleep may increase a person’s risk for developing dementia or Alzheimer’s disease ...

A recent study published in Nature Neuroscience provides evidence that lemborexant, a medication used to treat insomnia, can reduce brain damage linked to Alzheimer’s disease in a mouse model. The ...

Investigators later learned Chandler had prescriptions for zolpidem filled in Phillipsburg, DuBois and Butler County pharmacies. It was also revealed that Chandler wrote prescriptions for zolpidem ...

While heavy zolpidem use has been associated with increased risk of Alzheimer's disease, it is not clear if this increased risk was there because the drug was inhibiting oscillatory norepinephrine ...

The team then tested the impact of Zolpidem (a common sleep medication also known as Ambien or Zolpimist) on this system, and found that the norepinephrine waves during sleep decreased by 50 ...

PNN Ahmedabad (Gujarat) [India], November 27: Troikaa Pharma announced that it has launched its Zolpidem Sublingual Spray 3.85% w/v, for the treatment of short term insomnia under the brand name ...

Ambien (zolpidem) is a brand-name oral tablet that’s prescribed to help treat sleep problems in adults. As with other drugs, Ambien can cause side effects, such as nausea, dizziness, and unusual ...

Constipation is a side effect of Ambien, especially with prolonged use or overuse. However, it’s less common compared to other side effects. Zolpidem, commonly known by its brand name Ambien, is ...

Find patient medical information for Zolpidem on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...